$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Kenvue Shares Are Rising. Tylenol Litigation Fades Into the Rearview.
01:21pm, Tuesday, 19'th Dec 2023
A ruling hurts litigation against Kenvue that alleges a link between prenatal exposure to the company's Tylenol and autism spectrum disorder or ADHD.
Kenvue shares rise after favorable court ruling in Tylenol litigation
08:22am, Tuesday, 19'th Dec 2023
Shares of Tylenol maker Kenvue Inc. KVUE, +0.10% gained more than 5% premarket on Tuesday after a federal court judge in New York ruled that plaintiffs' expert testimony will be blocked in a case invo
Naval Task Force; Japanese Takeover
08:00am, Tuesday, 19'th Dec 2023
Naval Task Force; Japanese Takeover
Kenvue: A High-Quality Consumer Health Company on Sale
02:51pm, Tuesday, 12'th Dec 2023
In May, Kenvue Inc. (KVUE, Financial) successfully concluded its separation from Johnson & Johnson (JNJ, Financial); however, its stock has experienced a decline about 25% since the completion of this
Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul
03:42pm, Monday, 11'th Dec 2023
The last four years on Wall Street gave investors whiplash. A decade-long bull market came to a screeching halt as the global pandemic brought on one of the worst market crashes in recent memory.
3 Dividend Stocks Worthy Of A Buy In December 2023
09:37am, Monday, 04'th Dec 2023
November was the best month for the S&P 500 since July 2022, breaking a three-month losing streak. The stock market appears overvalued after the strong November performance, suggesting a minor pullbac
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
09:06am, Thursday, 30'th Nov 2023
The initial public offering (IPO) market has not done well in 2023. The most recent deals have faltered, falling below their IPO pricing on day one or soon after.
2023's most anticipated IPOs weren't always the big winners
06:05am, Wednesday, 29'th Nov 2023
So far in 2023, 146 companies have gone public in the U.S. markets, down 16.09% from the same time last year. Although the IPO market has been choppy amid higher interest rates and broad equity market
Kenvue: Dude, Where's My Dividend Growth?
11:21am, Sunday, 26'th Nov 2023
Dividend stocks became unattractive due to weak equities and high Treasury rates, but some are starting to look more attractive again. Kenvue, a spin-off from Johnson & Johnson, lacks growth potential
Top 5 Stocks The Smart Money Is Buying
09:38am, Tuesday, 21'st Nov 2023
Hedge funds are managed by professional fund managers and consist of pooled investment funds from various investors. Hedge funds must file a 13-F with the SEC, which shows their buys and sells for the
7 Safe Stocks to Buy if You Think Q3's Gangbuster Growth Won't Last
09:26am, Thursday, 09'th Nov 2023
At first glance, the proposal to dive into safe stocks to buy might appear overly conservative. As NPR recently pointed out, the U.S. GDP grew 4.9% in the third quarter, catalyzed by stronger-than-exp
U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO
12:21am, Saturday, 04'th Nov 2023
Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Index was up 23.5% year-to-date, while the S&P 500 was
The 3 Best Forever Stocks to Buy in November
08:42am, Friday, 03'rd Nov 2023
Anytime you bring up the concept of “forever stocks,” you're running the risk of incurring a serious tail risk. Obviously, forever is a long time – long enough for something to go wrong.
Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?
07:44am, Wednesday, 01'st Nov 2023
Kenvue stock pays a fairly high dividend that yields 4.4%. The company is expecting modest revenue growth of around 6% this year.
Kenvue Inc. (KVUE) Q3 2023 Earnings Call Transcript
01:48am, Saturday, 28'th Oct 2023
Kenvue Inc (NYSE:KVUE ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Tina Romani - Head of Investor Relations Thibaut Mongon - Chief Executive Officer and Director
Sign In
Buy KVUE